Clear Harbor Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.58M | Buy |
94,150
+1,825
| +2% | +$30.6K | 0.12% | 133 |
|
|
2025
Q1 | $1.42M | Sell |
92,325
-17,250
| -16% | -$265K | 0.11% | 133 |
|
|
2024
Q4 | $2.42M | Sell |
109,575
-6,500
| -6% | -$143K | 0.19% | 95 |
|
|
2024
Q3 | $2.09M | Buy |
116,075
+250
| +0.2% | +$4.51K | 0.17% | 101 |
|
|
2024
Q2 | $1.88M | Sell |
115,825
-5,000
| -4% | -$81.3K | 0.16% | 104 |
|
|
2024
Q1 | $1.7M | Sell |
120,825
-9,500
| -7% | -$134K | 0.15% | 118 |
|
|
2023
Q4 | $1.36M | Buy |
130,325
+63,225
| +94% | +$660K | 0.12% | 124 |
|
|
2023
Q3 | $684K | Buy |
67,100
+5,000
| +8% | +$51K | 0.07% | 177 |
|
|
2023
Q2 | $468K | Buy |
62,100
+55,100
| +787% | +$415K | 0.05% | 222 |
|
|
2023
Q1 | $62K | Buy |
+7,000
| New | +$62K | 0.01% | 359 |
|
|
2022
Q3 | – | Sell |
-298,680
| Closed | -$2.25M | – | 382 |
|
|
2022
Q2 | $2.25M | Buy |
298,680
+134,910
| +82% | +$1.01M | 0.3% | 66 |
|
|
2022
Q1 | $1.54M | Buy |
+163,770
| New | +$1.54M | 0.17% | 106 |
|
|
2020
Q1 | – | Sell |
-100
| Closed | -$980 | – | 619 |
|
|
2019
Q4 | $980 | Buy |
+100
| New | +$980 | ﹤0.01% | 747 |
|